This is a reopened ITT process, (the previous EU Supply project reference was 45233) to which some bidders have already responded. Commissioners have adjusted the financial model in the reopened process and provided greater clarity on how service activity will be funded.
NHS England Specialised Commissioning - Highly Specialised Commissioning Team (referred to as the Commissioner(s)) is inviting suitably qualified and experienced providers to express interest in delivering the Service(s), by responding to this opportunity as required and described in document 1, and within the published Provider Selection Process. NHS Arden and Greater East Midlands CSU (AGCSU) is acting as an agent for and on behalf of the Commissioner and is supporting the provider selection process.
The NHS Commissioning Board operating as NHS England - Specialised CommissioningLondonWAC-277266
Cystinosis is a very rare inherited lysosomal storage disease presenting in infancy (95% of cases) with severe kidney disease but subsequently involving multiple organs (eyes, thyroid, liver, diabetes, muscle deterioration). Patients often present to paediatric nephrology services although multi organ disease requires multi-speciality input. Effective drug therapy and renal transplantation has improved the life expectancy of these patients.
This project comprises a provider selection process to commission adult and paediatric cystinosis services.
The NHS Commissioning Board operating as NHS England - Specialised Commissioning LondonWAC-289279
NHS England and NHS Improvement (NHSE/I) South West (the Commissioner) sought a Provider who had the capability and capacity to deliver a Sexual Assault and Abuse Therapy service for individuals in Dorset.
The NHS Commissioning Board operating as NHS EnglandWAC-321341
NHS England and NHS Improvement South East (NHSE/I) sought to commission integrated healthcare services for prisons across the Thames Valley region. NHSE/I sought to secure Prime Provider(s) who have the capability and capacity to deliver services in line with the specified requirements.
The NHS Commissioning Board operating as NHS EnglandWAC-321869
Osteo-odonto-keratoprosthesis (OOKP) is a highly specialist surgical intervention that can restore meaningful vision to patients suffering from end stage corneal blindness, and for whom conventional corneal surgery is not possible for reasons such as severe ‘dry eyes’ that causes heavy scarring of the cornea. Osteo-odonto-keratoprosthesis (OOKP) uses the patient’s own tooth root and alveolar bone to support an optical cylinder and is only considered in end stage corneal disease when there is no other available treatment to restore sight. NHS England would like to identify NHS Trusts who are interested in delivering these services in accordance with the specification.
The NHS Commissioning Board operating as NHS England - Specialised CommissioningLondonWAC-318633